Evaluating the frequency of carbapenem and aminoglycoside resistance genes among clinical isolates of Acinetobacter baumannii from Ahvaz, south-west Iran
- PMID: 33194209
- PMCID: PMC7644744
- DOI: 10.1016/j.nmni.2020.100779
Evaluating the frequency of carbapenem and aminoglycoside resistance genes among clinical isolates of Acinetobacter baumannii from Ahvaz, south-west Iran
Abstract
Acinetobacter baumannii is one of the most important opportunistic challenging pathogens as a result of its ability to acquire resistance to broad range of antibiotics and cause a variety of severe nosocomial infections. We investigated the frequency of the aminoglycoside-modifying enzymes (AMEs) and oxacillinase genes among clinical isolates of A. baumannii collected from hospitalized patients in Imam Khomeini Hospital, Ahvaz city, Iran. This prospective cross-sectional study was performed on 80 clinical isolates of A. baumannii collected from patients referred to Imam Khomeini Hospital in Ahvaz, Iran. Initial identification of isolates as A. baumannii was performed using conventional bacteriologic tests, and final confirmation was carried out by PCR of bla OXA-51-like gene and multiplex PCR of gyrB locus. MICs of different classes of antibiotics against these strains was measured by using VITEK 2 system. After extraction of genomic DNA, two groups of multidrug-resistant A. baumannii genes including AME (aadA1, aadB, aphA6 and aacC1) and oxacillinases (bla OXA-23-like, bla OXA-24-like, bla OXA-51-like, bla OXA-58-like and bla OXA-143-like) were detected. According to antibiotic susceptibility testing, among 80 A. baumannii strains, 75 isolates (91.25%) were multidrug resistant. The results showed that colistin and tigecycline, with respective sensitivity rates of 97.5% (78/80) and 56.25% (45/80), had the highest effects. The presence of bla OXA-51-like and gyrB genes was confirmed in all strains. Furthermore, bla OXA-23-like and bla OXA-24-like genes were found in 68.75% (55/80) and 20% (16/80) of isolates respectively, while no isolate harbored the bla OXA-143-like gene. The frequency of genes encoding the AMEs including aadA1, aacC1, aphA6 and aadB were 11.25% (9/80), 16.25% (13/80), 22.5% (18/80) and 30% (24/80) respectively. Our findings indicate that the presence of the aadB and aphA6 is correlated with high resistance against amikacin and gentamicin. We found a very high resistance rate against most of the antimicrobial agents usually prescribed for severe infections caused by A. baumannii. Therefore, because of rapid emergence of resistance even for colistin or tigecycline, monotherapy should be avoided. These results show the importance of providing antibiotics correctly in intensive care units and following antibiotic stewardship protocols as the only effective strategies to attempt to control antibiotic resistance in healthcare settings.
Keywords: Acinetobacter baumannii; aminoglycoside resistance genes; carbapenem-resistant A. baumannii (CRAB); multidrug resistance (MDR); oxacillinase genes.
© 2020 The Author(s).
Similar articles
-
Characterization of Oxacillinase and Metallo-β-Lactamas Genes and Molecular Typing of Clinical Isolates of Acinetobacter baumannii in Ahvaz, South-West of Iran.Jundishapur J Microbiol. 2016 Feb 13;9(5):e32388. doi: 10.5812/jjm.32388. eCollection 2016 May. Jundishapur J Microbiol. 2016. PMID: 27540456 Free PMC article.
-
Prevalence of Aminoglycoside Resistance and Aminoglycoside Modifying Enzymes in Acinetobacter baumannii Among Intensive Care Unit Patients, Ismailia, Egypt.Infect Drug Resist. 2021 Jan 19;14:143-150. doi: 10.2147/IDR.S290584. eCollection 2021. Infect Drug Resist. 2021. PMID: 33519215 Free PMC article.
-
Genotyping of carbapenem resistant Acinetobacter baumannii isolated from tracheal tube discharge of hospitalized patients in intensive care units, Ahvaz, Iran.Iran J Microbiol. 2013 Dec;5(4):315-22. Iran J Microbiol. 2013. PMID: 25848498 Free PMC article.
-
Genotypic Patterns of Multidrug-Resistant Acinetobacter baumannii: A Systematic Review.Adv Biomed Res. 2023 Mar 21;12:56. doi: 10.4103/abr.abr_434_22. eCollection 2023. Adv Biomed Res. 2023. PMID: 37200758 Free PMC article. Review.
-
Control and management of multidrug resistant Acinetobacter baumannii: A review of the evidence and proposal of novel approaches.Infect Prev Pract. 2020 Jul 19;2(3):100077. doi: 10.1016/j.infpip.2020.100077. eCollection 2020 Sep. Infect Prev Pract. 2020. PMID: 34368717 Free PMC article. Review.
Cited by
-
Antimicrobial resistance and biofilm formation capacity among Acinetobacter baumannii strains isolated from patients with burns and ventilator-associated pneumonia.J Clin Lab Anal. 2023 Jan;37(1):e24814. doi: 10.1002/jcla.24814. Epub 2022 Dec 26. J Clin Lab Anal. 2023. PMID: 36573013 Free PMC article.
-
Evasion of Antimicrobial Activity in Acinetobacter baumannii by Target Site Modifications: An Effective Resistance Mechanism.Int J Mol Sci. 2022 Jun 13;23(12):6582. doi: 10.3390/ijms23126582. Int J Mol Sci. 2022. PMID: 35743027 Free PMC article. Review.
-
Synergistic combination of carvedilol, amlodipine, amitriptyline, and antibiotics as an alternative treatment approach for the susceptible and multidrug-resistant A. baumannii infections via drug repurposing.Eur J Clin Microbiol Infect Dis. 2023 Sep;42(9):1063-1072. doi: 10.1007/s10096-023-04634-5. Epub 2023 Jul 10. Eur J Clin Microbiol Infect Dis. 2023. PMID: 37428238
-
Evaluation of antibiotic resistance changes in Acinetobacter baumannii in the era of COVID-19 in Northern Iran.Iran J Microbiol. 2024 Jun;16(3):314-322. doi: 10.18502/ijm.v16i3.15762. Iran J Microbiol. 2024. PMID: 39005594 Free PMC article.
-
Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii with Special Reference to Carbapenemases: A Systematic Review.Infect Drug Resist. 2022 Dec 22;15:7631-7650. doi: 10.2147/IDR.S386641. eCollection 2022. Infect Drug Resist. 2022. PMID: 36579124 Free PMC article. Review.
References
-
- Mathlouthi N., El Salabi A.A., Jomàa-Jemili M.B., Bakour S., Al-Bayssari C., Zorgani Early detection of metallo-beta-lactamase NDM-1– and OXA-23 carbapenemase-producing Acinetobacter baumannii in Libyan hospitals. Int J Antimicrob Agents. 2016;48:46–50. - PubMed
-
- Rezaei A., Fazeli H., Moghadampour M., Halaji M., Faghri J. Determination of antibiotic resistance pattern and prevalence of OXA-type carbapenemases among Acinetobacter baumannii clinical isolates from inpatients in Isfahan, central Iran. Infez Med. 2018;26:61–66. - PubMed
LinkOut - more resources
Full Text Sources